Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages, Alveolar | 1 | 2021 | 66 | 0.660 |
Why?
|
| Receptors, Immunologic | 1 | 2021 | 139 | 0.650 |
Why?
|
| Monocytes | 1 | 2021 | 215 | 0.620 |
Why?
|
| Homeostasis | 1 | 2021 | 460 | 0.570 |
Why?
|
| Cancer-Associated Fibroblasts | 4 | 2022 | 40 | 0.540 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 157 | 0.510 |
Why?
|
| beta Catenin | 2 | 2014 | 265 | 0.450 |
Why?
|
| Lung | 1 | 2021 | 1365 | 0.430 |
Why?
|
| Tumor Microenvironment | 5 | 2022 | 555 | 0.420 |
Why?
|
| Th17 Cells | 2 | 2014 | 93 | 0.420 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 481 | 0.400 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 159 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 1339 | 0.370 |
Why?
|
| Cell Differentiation | 3 | 2021 | 1610 | 0.330 |
Why?
|
| Colitis | 1 | 2014 | 261 | 0.330 |
Why?
|
| Stromal Cells | 3 | 2021 | 151 | 0.330 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 101 | 0.330 |
Why?
|
| Colon | 1 | 2014 | 540 | 0.320 |
Why?
|
| Signal Transduction | 3 | 2021 | 3500 | 0.320 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 579 | 0.300 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 2756 | 0.270 |
Why?
|
| Cathepsins | 1 | 2007 | 22 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 3432 | 0.250 |
Why?
|
| Cysteine Endopeptidases | 1 | 2007 | 87 | 0.250 |
Why?
|
| T-Lymphocytes | 5 | 2022 | 1275 | 0.240 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 290 | 0.240 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 398 | 0.230 |
Why?
|
| Mice | 9 | 2023 | 12239 | 0.220 |
Why?
|
| Cell Proliferation | 5 | 2021 | 1735 | 0.220 |
Why?
|
| Up-Regulation | 1 | 2007 | 729 | 0.210 |
Why?
|
| Fibroblasts | 3 | 2023 | 752 | 0.210 |
Why?
|
| Membrane Proteins | 3 | 2020 | 1260 | 0.210 |
Why?
|
| B7-H1 Antigen | 3 | 2023 | 305 | 0.210 |
Why?
|
| Cell Lineage | 2 | 2021 | 321 | 0.190 |
Why?
|
| Gelatinases | 2 | 2020 | 10 | 0.180 |
Why?
|
| Cellular Senescence | 1 | 2023 | 106 | 0.180 |
Why?
|
| Apoptosis | 4 | 2021 | 1719 | 0.180 |
Why?
|
| Membrane Glycoproteins | 2 | 2021 | 443 | 0.180 |
Why?
|
| Neoplasms | 3 | 2023 | 3170 | 0.170 |
Why?
|
| Isoantigens | 1 | 2021 | 72 | 0.170 |
Why?
|
| Serine Endopeptidases | 2 | 2020 | 148 | 0.170 |
Why?
|
| Interleukin-6 | 1 | 2023 | 276 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 2 | 2020 | 347 | 0.170 |
Why?
|
| COS Cells | 1 | 2021 | 163 | 0.170 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2021 | 20 | 0.170 |
Why?
|
| Myeloid Cells | 1 | 2021 | 119 | 0.160 |
Why?
|
| Lymphocyte Activation | 2 | 2014 | 798 | 0.160 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 292 | 0.160 |
Why?
|
| Animals | 10 | 2023 | 28047 | 0.160 |
Why?
|
| Interleukin-8 | 1 | 2020 | 88 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 660 | 0.160 |
Why?
|
| Pharmacogenomic Variants | 1 | 2020 | 45 | 0.150 |
Why?
|
| Bone Marrow | 1 | 2021 | 409 | 0.150 |
Why?
|
| Lymph Nodes | 2 | 2021 | 548 | 0.150 |
Why?
|
| Proteomics | 1 | 2021 | 264 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 636 | 0.150 |
Why?
|
| Myofibroblasts | 1 | 2019 | 51 | 0.150 |
Why?
|
| Aging | 1 | 2023 | 727 | 0.140 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2019 | 131 | 0.140 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 223 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 424 | 0.130 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 1584 | 0.130 |
Why?
|
| T Cell Transcription Factor 1 | 2 | 2014 | 23 | 0.130 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 1061 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2014 | 80 | 0.130 |
Why?
|
| Cell Line | 1 | 2021 | 2458 | 0.130 |
Why?
|
| Intestines | 1 | 2020 | 432 | 0.120 |
Why?
|
| Mice, Knockout | 1 | 2021 | 2122 | 0.120 |
Why?
|
| Biomarkers, Tumor | 2 | 2021 | 1661 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 2301 | 0.110 |
Why?
|
| Humans | 13 | 2023 | 93609 | 0.110 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2014 | 18 | 0.100 |
Why?
|
| Genes, APC | 1 | 2014 | 25 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 797 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 2493 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 715 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 79 | 0.100 |
Why?
|
| Genomic Instability | 1 | 2013 | 88 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 1054 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 103 | 0.100 |
Why?
|
| CD4 Antigens | 1 | 2012 | 80 | 0.090 |
Why?
|
| Transgenes | 1 | 2012 | 171 | 0.090 |
Why?
|
| Lymphoma | 1 | 2013 | 246 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 457 | 0.090 |
Why?
|
| Binding Sites | 1 | 2014 | 1128 | 0.080 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 66 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 337 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2011 | 109 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 2368 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2011 | 523 | 0.080 |
Why?
|
| Endopeptidases | 2 | 2020 | 114 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2011 | 696 | 0.070 |
Why?
|
| Multiple Sclerosis | 1 | 2011 | 261 | 0.070 |
Why?
|
| Prognosis | 3 | 2021 | 3915 | 0.070 |
Why?
|
| Machine Learning | 2 | 2023 | 344 | 0.070 |
Why?
|
| Base Sequence | 2 | 2013 | 2209 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 959 | 0.070 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 200 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 1233 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 2889 | 0.070 |
Why?
|
| Cathepsin L | 1 | 2007 | 7 | 0.070 |
Why?
|
| Cytokines | 1 | 2011 | 863 | 0.060 |
Why?
|
| Response Elements | 1 | 2007 | 65 | 0.060 |
Why?
|
| Female | 5 | 2021 | 48778 | 0.060 |
Why?
|
| Immunotherapy | 2 | 2023 | 761 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2828 | 0.060 |
Why?
|
| Cell Survival | 2 | 2021 | 1003 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2007 | 281 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 3158 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2020 | 1002 | 0.050 |
Why?
|
| Male | 3 | 2021 | 44580 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2018 | 1102 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2020 | 697 | 0.050 |
Why?
|
| GPI-Linked Proteins | 1 | 2021 | 55 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1980 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2021 | 28 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 183 | 0.040 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2020 | 21 | 0.040 |
Why?
|
| Neutrophils | 1 | 2021 | 324 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2021 | 192 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 1025 | 0.040 |
Why?
|
| Multigene Family | 1 | 2020 | 202 | 0.040 |
Why?
|
| Clone Cells | 1 | 2020 | 219 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2020 | 207 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2020 | 293 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2020 | 229 | 0.040 |
Why?
|
| Urologic Neoplasms | 1 | 2020 | 78 | 0.040 |
Why?
|
| Pericytes | 1 | 2018 | 14 | 0.040 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2020 | 155 | 0.040 |
Why?
|
| Survival Rate | 1 | 2021 | 1951 | 0.030 |
Why?
|
| Stem Cells | 1 | 2020 | 386 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 281 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2020 | 1525 | 0.030 |
Why?
|
| Phenotype | 1 | 2023 | 2545 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 361 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 581 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 824 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 545 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1517 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 1103 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 761 | 0.030 |
Why?
|
| Genes, RAG-1 | 1 | 2013 | 11 | 0.030 |
Why?
|
| Thymocytes | 1 | 2013 | 31 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 3058 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2013 | 71 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2013 | 247 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2012 | 73 | 0.020 |
Why?
|
| Integrases | 1 | 2012 | 66 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2012 | 100 | 0.020 |
Why?
|
| DNA Repair | 1 | 2013 | 360 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2013 | 420 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 309 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2012 | 170 | 0.020 |
Why?
|
| Histones | 1 | 2013 | 361 | 0.020 |
Why?
|
| Spleen | 1 | 2012 | 374 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1115 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 9109 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 20469 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 27947 | 0.010 |
Why?
|